Close Menu
    What's Hot

    Memory Lane Cakes Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Utmost Life and Pensions

    September 1, 2026

    Wood Pension Plan Completes Bulk Purchase Annuity Buy-In With L&G

    September 1, 2026

    New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

    August 27, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

      August 27, 2026

      Pacific Life Re Completes Third Asset-Intensive Flow Reinsurance Transaction in Japan

      August 19, 2026

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      Memory Lane Cakes Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Utmost Life and Pensions

      September 1, 2026

      Wood Pension Plan Completes Bulk Purchase Annuity Buy-In With L&G

      September 1, 2026

      Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

      August 26, 2026

      New Stress Test Shows UK Bulk Purchase Annuity Insurers on Solid Ground

      August 26, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Wells Fargo Bank, N.A. v. Ameritas Life Insurance Corp

      August 26, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Memory Lane Cakes Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Utmost Life and Pensions

      September 1, 2026

      Wood Pension Plan Completes Bulk Purchase Annuity Buy-In With L&G

      September 1, 2026

      New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

      August 27, 2026

      Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

      August 26, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Encouraging Signs for Institutional Investors Looking at Reverse Mortgage Securitisations

    Secondary Life Markets February 12, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    The trend in reverse mortgage origination in the US in the past decade or so has been down, down, down. According to the National Reverse Mortgage Lenders Association, fiscal year 2024 – which, for the Department of Housing and Urban Development (HUD), ended on 30th September last year – delivered just 26,521 HECM mortgages, the lowest number since 2003 (18,097). 

    The story in the securitisation market has not been quite so negative, however. Tail issuance and growing loan balances over time provide additional capital that can be securitised to maintain healthy activity in the market. Indeed, HMBS issuance data from Ginnie Mae shows that December saw $575m worth of activity, the third best month since 2023. 

    “Over time, the HMBS market has expanded, despite lackluster HECM origination volume,” said Michael McCully, Partner at New View Advisors, “with the notable exception to that trend during the pandemic.” 

    “Because of agency – and particularly Ginnie Mae – liquidity in the secondary markets, lower volume has not proven to affect the depth of the market, trading, or pricing in HMBS. Low volume was a fear in 2010 when FHA made its first (and most dramatic) PLF reductions, but it proved not to be true.” 

    Then, in November, the market received a very welcome shot in the arm, as Ginnie Mae announced the terms for ‘HMBS 2.0’, the agency’s attempt at providing additional liquidity to the market. 

    First mooted more than a year ago, HMBS 2.0 notably increases the mandatory buyout threshold to 150% of the maximum claim amount (MCA, up from 98%), which, in aggregate, will provide significantly more flexibility to HMBS issuers before mandatory buyouts are required.  

    The impact of this on the availability of HMBS products for investors could be significant. 

    “Based on the final HMBS 2.0 term sheet, up to $431m per month of buyouts would have been eligible for HMBS 2.0 in 2024. That almost doubles HMBS volume, which was $6bn last year,” said McCully. 

    Other benefits of this development accrue to the institutional investor. The repurchase of loans at the original 98% MCA threshold leads to an acceleration of prepayments within the HMBS pool, so investors receive their principal back sooner than anticipated, which can affect the expected yield of the security. Additionally, early loan buyouts can disrupt the anticipated cash flows to investors, potentially leading to reinvestment risk, and by repurchasing the loans, issuers assume the associated credit risks until the loans are either assigned to HUD or otherwise resolved. 

    So, an encouraging development for capital allocators. But 2024 did not only deliver good news from the US market. Last July, the Australian market saw its first securitisation of reverse mortgages in many years when non-bank lender Household Capital issued securitised product rated by Moody’s. Joshua Funder, CEO at Household Capital, says that this is just the beginning. 

    “We expect to return to the securitisation market annually for the foreseeable future with increasing volumes of high quality, rated Australian variable rate reverse mortgage portfolios,” he said.  

    An interesting difference between the US and Australian markets is that the latter does not enjoy the benefits of having a federal backstop, something which provides great comfort to those with exposure to the US HMBS market. 

    That doesn’t mean that the risk profile of Australian product is significantly lower, however.  

    The passing of the Consumer Credit Legislation Amendment (Enhancements) Bill in 2012 by the country’s lawmakers provided a swath of consumer protections which, for the country’s reverse mortgage market, meant Australia has among the lowest loan-to-value reverse mortgage ratios in the world. 

    In 2018, the market received an additional boost as the Australian Securities and Investment Commission’s review of the performance of these regulations found no material breach, but it is not only the regulatory environment that supports risk management in the space. 

    “Australian reverse mortgages are variable rate, and those variable rates are correlated with long-term property price appreciation. This provides additional risk reduction for negative equity, equity erosion and bequest reduction,” said Funder. 

    “Additionally, Australian equity release customers tend to discharge voluntarily around 12% per annum, making the average weighted life around 8-9 years and de-coupling discharge from mortality alone and break fees.” 

    It is not just Funder who appears bullish on the market; an article in the November 2024 issue of the Australian Securitisation Journal by Moody’s says that the firm “expects Australian reverse mortgage and other equity release securitisation issuance to grow over time”. 

    The news story of the past few years in the primary equity release/reverse mortgages market has indeed been falling numbers of origination, as higher interest rates made these products more expensive for the consumer. 

    But now, things are looking up. Stateside, the Federal Reserve cut the Federal Funds Rate by 100bps in total in 2024, which should, other things being equal, drive demand; activity is pacing to deliver an increase this year. In the UK, green shoots appeared in the fourth quarter of last year.  

    And they are certainly looking up for the securitisation market, at least, in theory. US President Donald Trump’s federal hiring freeze, along with a raft of potential retirements, could delay the implementation of HMBS 2.0. But when it is finally implemented, institutional investors will have a larger menu from which to choose. 

    “As I said, we could see a doubling of HMBS volume thanks to the changes made by Ginnie Mae,” said McCully. 

    “More securitisation issuance provides more options to more investors. That, coupled with the expected increase in activity in the primary market, means that the next few years could see activity in the securitisation market reach new highs.” 

    2025 - February Equity Release / Reverse Mortgages Longevity Risk Mortality Risk Volume 4 Issue 2 - February 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

    August 26, 2026By Mark McCord
    Litigation

    Litigation Update: Wells Fargo Bank, N.A. v. Ameritas Life Insurance Corp

    August 26, 2026By Greg Winterton

    Q&A: Mitchell Schepps, Senior Managing Director, Aon

    August 26, 2026By Greg Winterton

    UK Equity Release Market Reverses Decline In Second Quarter With New Customer Increase

    August 5, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.